尊龙凯时·「中国区」官方网站

On June 28, 2024, Grand Pharma’s Wuhan Shetai Medical Technology Co., Ltd. (Wuhan Shetai Medical) signed a partnership agreement with Shanghai Maxin Health Technology Group Co. (Shanghai Maxin Health Technology Group Co., Ltd.) (MediTrust Health), a subsidiary of WSPA, signed an agreement in Wuhan on the cooperation of MMP insurance. According to the agreement, the two parties will carry out in-depth cooperation in the field of million-dollar medical insurance.

This cooperation will further promote the integration of resources and advantages in tumor treatment, health services, insurance and innovative business models, aiming to improve the quality of life of liver tumor patients and promote the development and innovation of China’s large health industry.

Mr. Huang Wentao, General Manager of Wuhan Shetai Medical, Mr. Zhang Chu, General Manager of the Product Development Department and the Production and Financing Innovation Department of China Re Life Insurance, Mr. Feng Hao, Vice President of Magnesium Health, and Mr. Liu Jian, Chairman of Beijing Pulwell, attended the ceremony on behalf of the parties.